Annichino-Bizzacchi JM - Search Results

1

Podoplanin and CLEC-2 levels in patients with COVID-19.

Borba-Junior IT, Lima F, Vitoria Rodrigues Oliveira DS, Peachazepi Moraes CR, Annichino-Bizzacchi JM, Bombassaro B, Palma AC, Maranhao Costa FT, Moretti ML, Mansour E, Velloso LA, Orsi FA, De Paula EV. Borba-Junior IT, et al. Among authors: annichino bizzacchi jm. Res Pract Thromb Haemost. 2023 Jun 21;7(5):100282. doi: 10.1016/j.rpth.2023.100282. Online ahead of print. Res Pract Thromb Haemost. 2023. PMID: 37361399 Free PMC article.

2

Venous thromboembolism in critically ill patients with pneumonia in the pre-COVID-19 era: Data from a large public database.

Pisani M, Orsi FA, Annichino-Bizzacchi JM, Barco S, De Paula EV. Pisani M, et al. Among authors: annichino bizzacchi jm. Res Pract Thromb Haemost. 2022 Oct 9;6(7):e12816. doi: 10.1002/rth2.12816. eCollection 2022 Oct. Res Pract Thromb Haemost. 2022. PMID: 36246480 Free PMC article.

3

Association of heme-oxygenase 1, hemopexin, and heme levels with markers of disease severity in COVID-19.

de Lima F, Moraes CRP, Barbosa MS, Bombassaro B, Palma AC, Dertkigil SSJ, Moretti ML, Orsi FA, Annichino-Bizzacchi JM, Mansour E, Velloso LA, De Paula EV. de Lima F, et al. Among authors: annichino bizzacchi jm. Exp Biol Med (Maywood). 2023 Feb;248(4):309-316. doi: 10.1177/15353702221139185. Epub 2023 Feb 5. Exp Biol Med (Maywood). 2023. PMID: 36740756 Free PMC article.

4

Increased adhesive properties of neutrophils and inflammatory markers in venous thromboembolism patients with residual vein occlusion and high D-dimer levels.

Zapponi KC, Mazetto BM, Bittar LF, Barnabé A, Santiago-Bassora FD, De Paula EV, Orsi FA, Franco-Penteado CF, Conran N, Annichino-Bizzacchi JM. Zapponi KC, et al. Thromb Res. 2014 May;133(5):736-42. doi: 10.1016/j.thromres.2014.01.035. Epub 2014 Feb 6. Thromb Res. 2014. PMID: 24560897

5

Long-term increased factor VIII levels are associated to interleukin-6 levels but not to post-thrombotic syndrome in patients with deep venous thrombosis.

Bittar LF, Mazetto Bde M, Orsi FL, Collela MP, De Paula EV, Annichino-Bizzacchi JM. Bittar LF, et al. Thromb Res. 2015 Mar;135(3):497-501. doi: 10.1016/j.thromres.2014.12.024. Epub 2014 Dec 31. Thromb Res. 2015. PMID: 25575413

6

Clinical implications of the detection of antibodies directed against domain 1 of β2-glycoprotein 1 in thrombotic antiphospholipid syndrome.

Montalvão S, Elídio PS, da Silva Saraiva S, de Moraes Mazetto B, Colella MP, de Paula EV, Appenzeller S, Annichino-Bizzacchi J, Orsi FA. Montalvão S, et al. Thromb Res. 2016 Dec;148:32-37. doi: 10.1016/j.thromres.2016.10.001. Epub 2016 Oct 4. Thromb Res. 2016. PMID: 27770664

7

Prolonged APTT of unknown etiology: A systematic evaluation of causes and laboratory resource use in an outpatient hemostasis academic unit.

Barbosa ACN, Montalvão SAL, Barbosa KGN, Colella MP, Annichino-Bizzacchi JM, Ozelo MC, De Paula EV. Barbosa ACN, et al. Res Pract Thromb Haemost. 2019 Sep 8;3(4):749-757. doi: 10.1002/rth2.12252. eCollection 2019 Oct. Res Pract Thromb Haemost. 2019. PMID: 31624795 Free PMC article.

8

A retrospective analysis of 122 immune thrombocytopenia patients treated with dapsone: Efficacy, safety and factors associated with treatment response.

Colella MP, Orsi FA, Alves ECF, Delmoro GF, Yamaguti-Hayakawa GG, de Paula EV, Annichino-Bizzacchi JM. Colella MP, et al. J Thromb Haemost. 2021 Sep;19(9):2275-2286. doi: 10.1111/jth.15396. Epub 2021 Aug 9. J Thromb Haemost. 2021. PMID: 34018665 Free PMC article.

9

Neutrophil activation and circulating neutrophil extracellular traps are increased in venous thromboembolism patients for at least one year after the clinical event.

Zapponi KCS, Orsi FA, Cunha JLR, de Brito IR, Romano AVC, Bittar LF, De Paula EV, Penteado CF, Montalvão S, Annichino-Bizzacchi JM. Zapponi KCS, et al. J Thromb Thrombolysis. 2022 Jan;53(1):30-42. doi: 10.1007/s11239-021-02526-z. Epub 2021 Aug 27. J Thromb Thrombolysis. 2022. PMID: 34449018 Free PMC article.

10

Contact and intrinsic coagulation pathways are activated and associated with adverse clinical outcomes in COVID-19.

Henderson MW, Lima F, Moraes CRP, Ilich A, Huber SC, Barbosa MS, Santos I, Palma AC, Nunes TA, Ulaf RG, Ribeiro LC, Bernardes AF, Bombassaro B, Dertkigil SSJ, Moretti ML, Strickland S, Annichino-Bizzacchi JM, Orsi FA, Mansour E, Velloso LA, Key NS, De Paula EV. Henderson MW, et al. Among authors: annichino bizzacchi jm. Blood Adv. 2022 Jun 14;6(11):3367-3377. doi: 10.1182/bloodadvances.2021006620. Blood Adv. 2022. PMID: 35235941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

149 results

Search Page